Transcription factors lie at the center of gene regulation, and their identification is crucial to the understanding of transcription and gene expression. Traditionally, the isolation and identification of transcription factors has been a long and laborious task. We present here a novel method for the identification of DNA-binding proteins seen in electrophoretic mobility shift assay (EMSA) using the power of two-dimensional electrophoresis coupled with mass spectrometry. By coupling SDS-PAGE and isoelectric focusing to EMSA, the molecular mass and pI of a protein complex seen in EMSA were estimated. Candidate proteins were then identified on a two-dimensional array at the predetermined pI and molecular mass coordinates and identified by mass spectrometry. We show here the successful isolation of a functionally relevant transcription factor and validate the identity through EMSA supershift analysis. The isolation and identification of sequence-specific DNAbinding proteins is not trivial. The first step involves the mapping of promoter regions that interact with potential transcription factors. DNase I footprinting and electrophoretic mobility shift assays (EMSA) 1 are generally employed for the rapid characterization of such regions including the definition of cis-acting elements (1). If the defined DNA elements conform to consensus transcription factor binding sites, and if specific antibodies are available, then EMSA supershifts can be employed to possibly identify the interacting proteins. However, if appropriate supershift antibodies are not available, then EMSA is of limited value in the identification of novel DNA-binding proteins.
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The isolation and identification of sequence-specific DNAbinding proteins is not trivial. The first step involves the mapping of promoter regions that interact with potential transcription factors. DNase I footprinting and electrophoretic mobility shift assays (EMSA) 1 are generally employed for the rapid characterization of such regions including the definition of cis-acting elements (1) . If the defined DNA elements conform to consensus transcription factor binding sites, and if specific antibodies are available, then EMSA supershifts can be employed to possibly identify the interacting proteins. However, if appropriate supershift antibodies are not available, then EMSA is of limited value in the identification of novel DNA-binding proteins.
The traditional route to the identification of cognate transacting factors, the biochemical isolation and identification of DNA-binding proteins, is usually a long and labor-intensive process. Purification of transcription factors often involves four or five different chromatographic steps, including ion exchange, gel filtration, and nonspecific and sequence-specific DNA affinity columns (2). The major impediment to the rapid identification of a transcription factor of interest is the fact that they are generally present in low concentrations, usually less than 0.1% of the total nuclear protein. Additionally they often bind with moderate affinity (3). Recent advents in proteomics and mass spectrometry have created unprecedented power in protein identification. For example, proteins have recently been analyzed directly by matrix-assisted laser desorption ionization time-of-flight mass spectrometry utilizing DNA probes harboring specific sequence motifs (4) .
In this paper, we have developed a powerful method for the identification of DNA-binding proteins seen in EMSA. Utilizing the power of two-dimensional electrophoresis (2DE) and mass spectrometry (MS), we have established a novel technique to isolate transcription factors. More importantly, our method obviates the need for laborious and extensive purification of the protein of interest. In this paper, the methodology required and the successful isolation of a functionally relevant transcription factor have been described using our novel proteomics approach.
We were interested in the identity of an EMSA complex that bound to a CCAT repeat sequence. This repeat forms part of a functionally important microsatellite repressor sequence within the CD30 promoter (5) . Traditional methods such as sequence-specific DNA affinity chromatography, coupled with chromatographic purification of nuclear proteins, proved unsuccessful because of the high abundance and affinity of nonspecific nuclear proteins. Instead, by estimating the pI and molecular mass (MM) of the protein by coupling SDS-PAGE or isoelectric focusing (IEF) with EMSA, it was possible to identify candidate protein spots on a two-dimensional array of nuclear proteins. These candidates were characterized further by excision from a two-dimensional gel at the predetermined pI and MM. Proteins were then eluted, renatured, and tested for original activity in EMSA, and candidate spots were subsequently analyzed by mass spectrometry, and their identity was determined. Finally, we confirmed the identity of the protein isolated via our novel method using EMSA supershift analysis. An overview of the method is shown in Fig. 1 .
EXPERIMENTAL PROCEDURES
Nuclear Extract Preparation and S-300 Gel Filtration-Jurkat (T cell) cell lines were obtained from ATCC and maintained in RPMI 1640 medium with 2 mM L-glutamine, 100 g/ml each of streptomycin and penicillin, and 10% fetal bovine serum at 37°C with 5% CO 2 . Cells were harvested at a density of 8 ϫ 10 5 cells/ml, and nuclear extracts were prepared essentially as described previously (6) . Nuclear extracts were then subjected to an ammonium sulfate cut (0.33 g/ml extract) and pelleted by centrifugation as described previously (7). The resulting extract was then dissolved in TM buffer (50 mM Tris-Cl, pH 7.9, 100 mM KCl, 12.5 mM MgCl 2 , 1 mM EDTA, 10% glycerol (v/v)) and loaded onto a HiPrepா Sephacryl S-300 high resolution column (Amersham Biosciences). Fractions were snap-frozen in liquid N 2 and stored at Ϫ80°C. Determination of protein concentration of the fractions was performed using the Bio-Rad protein assay kit (Bio-Rad) according to the manufacturer's protocol.
SDS-PAGE MM Fractionation-MM determination of unknown proteins by SDS-PAGE was performed as described previously (8) . Briefly, concentrated crude Jurkat nuclear extract (60 g) was denatured in standard SDS loading buffer for 5 min at 95°C. Proteins were electrophoresed at 240 V on an 8% SDS-polyacrylamide gel (9) , and the lane containing nuclear extract was sliced uniformly into molecular mass intervals. Gel slices were crushed into 1.5 volumes of renaturation buffer (3% Triton X-100, 20 mM Hepes, 100 mM NaCl, 5 mg/ml bovine serum albumin, 3 mM ZnCl 2 , 3 mM MgCl 2 , 2 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, 0.1 mM benzamidineHCl) and incubated overnight at 4°C. The polyacrylamide was pelleted by centrifugation, and the supernatant was then assayed for DNA binding activity in EMSA. Additionally, molecular mass standards were used to determine the molecular mass intervals of the excised gel slices.
IEF Analysis-S-300 fractionated nuclear extract (180 g) was resuspended in rehydration solution (8 M urea, 4% CHAPS, 0.5% IPG buffer, 2 mM tributyl phosphine) using ULTRAFREE centrifugal filters (Millipore). Four successive concentration and reconstitution cycles in rehydration solution ensured both buffer exchange and removal of salts for IEF. The samples (250 l) were then loaded onto IPG Drystrips (13 cm; pH 3-10 linear or 4 -7 linear) (Amersham Biosciences) and loaded onto an IPGphor (Amersham Biosciences) electrofocusing unit before commencing the following protocol: 12 h rehydration; 100 V for 100 V-h, 250 V for 250 V-h, 500 V for 1000 V-h, 1000 V for 2000 V-h, 8000 V for 60,000 V-h. Following IEF, strips were rocked in equilibration solution containing no urea (50 mM Tris, 30% glycerol (v/v), 2% SDS (w/v), 2 mM tributyl phosphine) for 15 min. IPG strips were sliced uniformly into pI intervals, the gel slices were crushed into 2 volumes of renaturation buffer, and the fractions were incubated overnight at 4°C. The polyacrylamide was pelleted by centrifugation, and the supernatant was assayed for DNA binding activity using EMSA.
EMSA Analysis-Nuclear proteins were assayed for binding activity using an oligonucleotide containing 12 copies of a 4-bp repeat, 5Ј-G(C/C/A/T) 12 -3Ј, labeled with 32 P[dCTP] using Klenow fragment. Nuclear proteins (2 g) or pI/MM fractions (12.5 l) were incubated for 10 min on ice with 1 g of poly(dI⅐dC) in binding buffer consisting of 4% Ficoll, 20 mM HEPES, pH 7.9, 1 mM EDTA, 1 mM dithiothreitol, 50 mM KCl. Proteins were then incubated with the 32 P-labeled oligonucleotide for 30 min on ice prior to being loaded onto a 6% polyacrylamide gel containing 0.25ϫ Tris-taurine/EDTA. Gels were electrophoresed at 150 V for 3 h, dried, and exposed to x-ray film at Ϫ80°C. Where indicated 500 ng of anti-YY1 (Yin Yang 1) antibody (Santa Cruz Biotechnology, Inc.) was incubated with extract for 10 min on ice prior to probe addition.
Two-dimensional Electrophoresis-Following IEF, strips were rocked in equilibration solution (6 M (v/v), 2% SDS (w/v), 2 mM tributyl phosphine) for 30 min. Strips were rinsed briefly in SDS running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS (w/v)) prior to being sealed into the top of a 10% SDS-polyacrylamide gel with 0.5% agarose in SDS running buffer. Electrophoresis was performed at 20 mA until the dye front reached the anodic end of the gels. Gels were subsequently stained using the silver staining kit (Amersham Biosciences) as per the manufacturer's instructions. Alternatively, colloidal Coomassie Blue G250 was used if MS was being performed.
Matrix-assisted Laser Desorption Ionization Time-of-Flight (MALDI-TOF) MS-Spots
of interest were excised from 2DE gels, placed in microtiter plates and subjected to MALDI-TOF MS (Australian Proteome Analysis Facility). Samples were subjected to a 16-h tryptic digest at 37°C. Peptides were extracted from the gel using a 50% (v/v) acetonitrile, 1% (v/v) trifluoroacetic acid solution. A 1-l aliquot was spotted onto a sample plate with 1 l of matrix (␣-cyano-4-hydroxycinnamic acid, 8 mg/ml in 40% acetonitrile (v/v), 1% trifluoroacetic acid), and MALDI-TOF analysis was performed on a Micromass Tofspec time-of-flight mass spectrometer.
Protein Identification-The peptide masses obtained from MALDI-TOF spectra were analyzed using NCBI databases and utilizing the MS-FIT database tool located at the ProteinProspector website (10) . Monoisotopic peaks were searched against human proteins, 1-100 kDa, with a maximum of one missed cleavage, unmodified cysteines, and with a mass tolerance of 100 ppm.
RESULTS

Partial Purification of Complex E by S-300 Gel Filtration-
Binding of crude Jurkat nuclear extract to an oligonucleotide containing 12 CCAT repeat sequences resulted in the formation of one major and a number of minor DNA protein complexes designated A, B, D, and E (Fig. 2, lane NE) . We were interested in identifying the components of complex E that bound to this repeat sequence. Jurkat nuclear extracts were fractionated using Sephacryl S-300 gel filtration. Resulting fractions were analyzed for complex E activity by EMSA. Fractionation of the extract resulted in partial purification of complex E, as activity was detected mainly in fraction 39 (Fig.  2, lane F39) .
FIG. 3. Complex E contains a monomeric protein of 55-66 kDa.
Crude nuclear extract was analyzed by SDS-PAGE, and MM fractions were isolated in gel slices. Proteins were eluted, renatured, and tested for complex E activity in EMSA. Complex E activity was detected in the 55-66-kDa fraction (see arrow). Protein complexes are indicated with arrows. Unbound radiolabeled oligonucleotide is indicated as Free Probe.
FIG. 4.
Complex E has a denatured pI of ϳ5.8. Fraction 36 was analyzed by IEF, and pI fractions were isolated in gel pieces. Proteins were eluted, renatured, and tested for complex E activity in EMSA. Peak complex E activity was detected in pI fractions 5.6 -5.8 and 5.8 -6.15. Blank denotes radiolabeled probe alone, NE shows binding of oligonucleotide to 2 g of crude nuclear extract, and F36 denotes 1 g of S300 fraction 36. Protein-DNA complexes are marked with arrows, and pI fractions are as illustrated.
Complex E Is a Monomeric Protein of 55-66 kDa-Concen-
trated crude nuclear extract was analyzed by SDS-PAGE, and fractions of discrete molecular mass intervals were excised and eluted from the gel. Proteins of each fraction were renatured and tested for complex E activity in EMSA. Complex E activity was detected in the 55-66-kDa fraction (Fig. 3, lane  55-66 ). This lane also contains two other complexes that are not seen in the crude nuclear extract binding profile. These complexes may represent multimers of complex E constituents and suggested that complex E is most likely a monomer or homomeric protein complex although it was possible that it consisted of heteromeric subunits that were within the same molecular mass range.
Denatured Complex E Has a pI of ϳ5.8 -Sephacryl 300 fractionation demonstrated that fraction 36 (Fig. 1, lane F36 ) contained significant activity of complexes D and E, and to preserve the complex E peak fractions this fraction was used to determine the pI of complex E. Peak complex E activity was detected in two intervals, pI 5.6 -5.8 and 5.8 -6.15 with lower activity detected in neighboring intervals (Fig. 4) . This result suggested that the pI of complex E is ϳ5.8. Complex D activity was also reconstituted, and peak activity was seen in the pI 5.1-5.35 interval with lower activity in neighboring intervals. Also another complex, which was not seen in the crude nuclear extract binding profile, was seen with peak activity in the pI 4.8 -5.1 interval. This complex may represent a nonspecific DNA-binding protein that is normally out competed in the S300 fractions but is able to bind in the IEF-purified fraction.
Two-dimensional Analysis of Complex E-
The results indicated that complex E is a 60-kDa protein with a denatured pI of ϳ5.8. To confirm these characteristics, nuclear proteins of fraction 39, the peak E fraction, were analyzed by two-dimensional electrophoresis over an IPG of pH 4 -7 and transferred to an SDS-polyacrylamide gel. The region of interest was excised (MM 52-65, pI 5.5-6.0) and was dissected into 20 quadrants each corresponding to discrete MM and pI intervals (Fig. 5A) . The proteins from each gel slice were eluted with re-naturation buffer and assayed for complex E activity using EMSA. Peak complex E activity was detected in gel slices 10 and 11 corresponding to pI intervals of 5.65-5.75 and 5.75-5.85, respectively, and a MM of 57-59 kDa. Smaller complex E activity was detected in neighboring fractions 6, 7, 14, and 15, which represent the same pI intervals, but neighboring MM intervals 54.5-57 kDa and 59 -62 kDa (Fig. 5B) .
These results confirmed our earlier estimates of MM (Fig. 3 ) and pI (Fig. 4) of complex E. Examination of the excised region on a silver-stained gel indicated four candidate protein spots that were located within the quadrants that contained complex E activity. Candidates were denoted E1, E2, E3, and E4 (Fig. 5A) , and the identity of these proteins spots was elucidated using MALDI-TOF MS.
Mass Spectrometry Identified YY1 as a Candidate for Complex E-Two-dimensional electrophoresis of fraction 39 was repeated, and the resulting 2DE gel was stained with colloidal Coomassie Blue because of its compatibility with mass spectrometry. Two candidate protein spots were excised (Fig. 5A,  E2 and E4) , one from each quadrant, digested with trypsin and analyzed by MALDI-TOF MS, and monoisotopic peaks were searched against the NCBI database.
Protein spot E4 matched the transcriptional repressor protein YY1 (Table I) . YY1 is a zinc finger transcription factor with a pI of 5.8 and an apparent molecular mass of 60 -68 kDa (11, 12) , properties similar to our estimated MM and pI of the protein within complex E. Protein spot E2 also matched some YY1 peptides, although because of keratin contamination it had a significantly lower MOWSE score (data not shown).
TABLE I Protein spot E4 matches the transcriptional repressor YY1
Protein spot E4 were analyzed by MALDI-TOF MS analysis. Monoisotopic peaks were searched against the NCBI protein database for human proteins 1-100 kDa in size with a maximum of one missed cleavage, unmodified cysteines, and with a mass tolerance of 100 ppm. The database was searched using the MS-FIT database tool located at the ProteinProspector website (10) . The top five matches for protein spot E4 are shown. The top three matches identify the transcription factor YY1, as well as alternatively named species of YY1 (NF-E1). 5 . Two-dimensional analysis of complex E. Fraction 39 was analyzed by two-dimensional electrophoresis and resolved on an SDS-polyacrylamide gel and silver-stained. A, the resulting two-dimensional gel had the region of interest excised between pI 5.5-6.0 and MM 52-65 kDa, which was dissected into 20 quadrants as shown. B, EMSA of eluted proteins. Quadrants had proteins eluted, renatured, and tested for complex E binding activity in EMSA. Peak complex E activity was detected in quadrants 10 and 11, corresponding to four candidate protein spots labeled E1, E2, E3, and E4 in A. NE shows oligonucleotide binding to 2 g of crude nuclear extract, and F39 designates 1 g of S300 fraction 39. Protein-DNA complexes are indicated with arrows. Blank, unbound oligonucleotide.
Protein spot E3 was not analyzed by MALDI-TOF MS but most likely represents a differentially modified form of YY1. Indeed, YY1 does contain several phosphorylation sites that may represent different protein spots on a two-dimensional array (13) .
EMSA Supershift Confirms Complex E Is YY1-To verify the identity of complex E as YY1 and to validate our technique, anti-YY1 antibodies were used in EMSA to determine whether they were able to cause a supershift of complex E. Fraction 39 was utilized in the supershift as it forms only complex E in EMSA (Fig. 6, Control) . The addition of anti-YY1 antibodies generated two supershifted complexes when compared with a negative control, where no antibody was added (Fig. 6 , lane ␣YY1), confirming that complex E does indeed contain YY1.
DISCUSSION
Transcription factors are essential regulators of gene expression. The purification and identification of these factors is crucial to the understanding of their effect on transcription. In the past, the isolation and identification of DNA-binding proteins has been a long and laborious task. Here we present a method for the identification of DNA-binding proteins seen in EMSA that utilizes the power of 2DE, coupled with mass spectrometry.
EMSA is a sensitive technique for the detection and characterization of DNA-binding proteins in vitro. If candidate DNA-binding proteins can be determined by binding site similarity, then appropriate antibodies can be utilized in EMSA, and activity of the transcription factor can be confirmed. However, if no candidates can be determined, EMSA is of limited utility in the identification of novel DNA-binding proteins.
We were interested in the identity of a DNA-binding protein seen in EMSA that was able to bind to a CCAT repeat sequence, which was unable to be characterized previously using standard purification protocols. Recent advances in mass spectrometry would likely enable identification of the transcription factor through liquid chromatography tandem mass spectrometry to identify common proteins isolated from both the SDS-PAGE gel and the IEF gel. However, coupling 2DE gel electrophoresis with EMSA was determined to be advantageous as simple MALDI-based analysis can be used. Another advantage is because of the fact that the protein complex of interest in EMSA can be directly purified from the same nuclear protein sample without the need for extensive purification. Resolution on a 2DE gel results in less complex results as the transcription factors are further purified into single spots that can also be re-tested in EMSA. Furthermore, our method allows determination of physical properties (pI and MM and modification status) of the protein complex, which will ultimately aid in identification of the functionally relevant transcription factor.
We have presented a novel technique for the identification of DNA-binding proteins seen in EMSA; however as with any method there are several pre-conditions. The determination of the pI and MM of the protein rely on the ability of the protein to re-form a functional conformation following the denaturing conditions of SDS-PAGE and IEF. Here we use a previously published protocol (8) that elutes denatured proteins into a renaturation buffer containing a mild non-ionic detergent, Triton X-100, that is able to sequester SDS in micelles, preventing it from interfering with protein-DNA interactions. The ability to re-form functional conformations following denaturation is critical to the identification process although even if efficiency of renaturation is very low, activity can be detected in EMSA. Also, the denaturing conditions of SDS-PAGE and IEF will dissociate and separate subunits of a DNA binding complex. Thus, the DNA-binding protein of interest must bind DNA as either a monomer or homomer. Multi-subunit complexes must contain subunits that possess very similar MM and pI values, otherwise the subunits will be separated upon pI and MM fractionation and will not be reformed for analysis by EMSA.
Finally, the DNA-binding protein must resolve in 2DE and be identifiable by mass spectrometry. Many hydrophobic and mildly soluble proteins suffer from poor resolution or are lost during IEF (14) . As such, the DNA-binding protein of interest should be readily soluble to avoid complications with 2DE and contain few post-translational modifications to aid mass spectrometric identification.
This technique has proven of general utility in identifying DNA-binding proteins seen in EMSA without the need for extensive purification of the protein of interest. We have used this technique to identify other EMSA binding activities such as Sp2 (data not shown). DNA-binding proteins, especially transcription factors, lie at the center of gene regulation, and thus the identification of unknown factors is crucial to the understanding of transcriptional regulation. Recent advances in mass spectrometry and proteomics have provided rapid and accurate techniques for protein identification and will allow the identification of many transcription factors without the need for tedious purification techniques.
